Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Ginkgo Bioworks Holdings, Inc. Class A Common Stock (NY:DNA)

14.22 +1.88 (+15.18%)
Delayed Quote Updated: 12:49 PM EDT, Oct 5, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Ginkgo Bioworks Holdings, Inc. Class A Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
17 18 Next >
News headline image
This Small-Cap Stock Announced a Deal With Eli Lilly. Then Its Shares Doubled ↗
Eli Lilly is partnering with Ginkgo Bioworks on drug discovery. 
Via The Motley Fool
Topics Artificial Intelligence
News headline image
Ginkgo Datapoints Announces Partnership with TuneLab to Close the Gap between AI Models and Lab Data
From Ginkgo Bioworks
Via Business Wire
News headline image
Ginkgo Bioworks Joins ARPA-H GIVE Program to Build Autonomous Manufacturing System for Individualized RNA Medicines
From Ginkgo Bioworks
Via Business Wire
Ginkgo Bioworks Holdings (NYSE:DNA) tumbles 15% in after-hours trading after Q1 revenue and earnings miss analyst estimates ↗
Via Chartmill
Topics Earnings
News headline image
Earnings Scheduled For November 6, 2025 ↗
 
Via Benzinga
News headline image
Earnings Scheduled For August 7, 2025 ↗
 
Via Benzinga
News headline image
Earnings Scheduled For May 6, 2025 ↗
 
Via Benzinga
News headline image
Earnings Scheduled For February 25, 2025 ↗
 
Via Benzinga
News headline image
Ginkgo Bioworks Q2 Earnings Call Highlights ↗
Ginkgo Bioworks (NYSE:DNA) reported second-quarter 2026 revenue of $20 million, down 48% from the year-earlier period, as the company continued to shift its focus toward autonomous laboratory systems,... 
Via MarketBeat
Topics Earnings
News headline image
Palantir's Bold Biosecurity Opportunity Could Be Bigger Than Investors Think ↗
A new biosecurity theme is emerging, and Palantir is leveraging it as an opportunity. Here's why that divide could matter for investors. 
Via The Motley Fool
News headline image
Ginkgo Bioworks Q1 Earnings Call Highlights ↗
Ginkgo Bioworks (NYSE:DNA) said it is sharpening its 2026 focus on autonomous laboratories after completing the divestiture of its biosecurity business and reporting lower year-over-year cash burn in... 
Via MarketBeat
Topics Artificial Intelligence Earnings
News headline image
Ginkgo Bioworks (DNA) Q1 2026 Earnings Transcript ↗
Ginkgo Bioworks (DNA) Q1 2026 Earnings Transcript 
Via The Motley Fool
Topics Artificial Intelligence
Let's have a look at the top gainers and losers one hour before the close of the markets of today's session. ↗
Via Chartmill
Which stocks are moving on Friday? ↗
Via Chartmill
What's going on in today's pre-market session ↗
Via Chartmill
Wondering what's happening in today's after-hours session? ↗
Via Chartmill
News headline image
Moss, Microbes, and the Martian Dream: How Tiny Organisms Are Paving the Way for Off-World Colonies
The ambitious dream of humanity establishing permanent settlements beyond Earth is taking a significant leap forward, not through advanced robotics or colossal spacecraft, but with the humble power of... 
Via TokenRing AI
Topics Artificial Intelligence Economy
News headline image
Ginkgo Bioworks Stock Plummets Following Q3 Estimates Miss, Reaffirms FY2025 Outlook Below Consensus ↗
Ginkgo Bioworks Holdings Inc (NYSE:DNA) shares are trading lower on Friday. The company released its third-quarter financial results. 
Via Benzinga
News headline image
Dell, Select Medical, Century Aluminum And Other Big Stocks Moving Higher On Wednesday ↗
 
Via Benzinga
News headline image
AI Unlocks Secrets of Intrinsically Disordered Proteins: A Paradigm Shift in Biomedical Design
A groundbreaking advancement in artificial intelligence has opened new frontiers in understanding and designing intrinsically disordered proteins (IDPs), a class of biomolecules previously considered... 
Via TokenRing AI
Topics Artificial Intelligence Derivatives
News headline image
Ginkgo Datapoints and Apheris Launch Antibody Developability Consortium
From Ginkgo Bioworks
Via Business Wire
News headline image
5 Healthcare Stocks On Fire This Week ↗
Healthcare stocks SNOA, EVOK, KALA, DNA, & SNGX soar with massive momentum gains, signaling breakout potential in biotech & pharma. 
Via Benzinga
News headline image
Ginkgo Bioworks Holdings Inc (NYSE:DNA) Fits the Minervini Trend Template with Strong Technicals and High-Growth Momentum ↗
Ginkgo Bioworks (DNA) meets Minervini Trend Template criteria with strong technicals, earnings growth, and momentum, making it a high-growth stock to watch. 
Via Chartmill
News headline image
Hewlett Packard Enterprise, Magnite, GMS And Other Big Stocks Moving Higher On Monday ↗
 
Via Benzinga
News headline image
Twist Bioscience and Ginkgo Bioworks Revise Collaboration
From Twist Bioscience Corporation
Via Business Wire
News headline image
Nvidia-Backed Recursion, Ginkgo Bioworks Rally Following FDA's Decision To End Animal Testing ↗
FDA announces plan to end mandatory animal testing of new drugs, replacing it with more effective and human relevant methods. 
Via Benzinga
Topics Animal Testing
News headline image
Fastenal Posts Better-Than-Expected Sales, Joins Simulations Plus, Certara And Other Big Stocks Moving Higher On Friday ↗
 
Via Benzinga
News headline image
Flywire Posts Downbeat Results, Joins Lemonade, Ginkgo Bioworks And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session ↗
 
Via Benzinga
News headline image
US Stocks Likely To Open Higher Ahead Of Nvidia Earnings: S&P 500's Four-Day Fall Was A 'Non-Event,' Says Expert ↗
U.S. stock futures rose on Wednesday following two consecutive days of mixed close this week. All futures advanced in premarket trading. 
Via Benzinga
Topics Stocks
News headline image
Why ZoomInfo Technologies Shares Are Trading Higher By Around 20%; Here Are 20 Stocks Moving Premarket ↗
 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9
...
17 18 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.